Abstract:Background Procalcitonin (PCT) is efficient in reducing antibiotic usage without increasing complications for its sensitivity and specificity in detecting bacterial infection. However, its role in guiding antibiotic-spectrum escalation has not been studied. This study was performed to validate the role of PCT in indicating antibiotic spectrum escalation when pathogen results are unknown for ICU patients of suspected bacterial infections. Methods This was a single-center retrospective study including patients who were admitted to Peking Union Medical College Hospital from January 2014 to June 2018 for suspected bacterial infections. Patients were divided into “escalation” or “non-escalation” groups according to the change of employed antibiotic spectrum before and after the occurrence of “PCT alert”. The main study endpoint was the length of ICU stay (LIS), and LIS longer than 7 days was defined as “prolonged-ICU-stay (PIS)” while LIS equal to or shorter than 7 days was defined as “non-prolonged-ICU-stay(nPIS)”. Demographics, clinical characteristics, and infection characteristics were compared between patients in the “nPIS” and “PIS” groups. Multivariable logistic regression was used to evaluate independent risk factors for PIS. Results Totally, 1109 patients were included, and 654 in the PIS group, other 455 in the nPIS group. Respiratory infection was the main cause in both groups. Patients were older in PIS group than in nPIS group(PIS vs. nPIS: 58.99 ± 16.30 vs. 56.12 ± 15.93 years, P=0.002). The baseline Sequential Organ Failure Assessment (SOFA) score was 11.16 ± 7.33 and 9.73 ± 3.70 in PIS and nPIS groups. Fewer patients received antibiotic escalation in face of “PCT alert” in PIS group (PIS vs. nPIS: 27.68 vs.35.38%, P=0.014). In the multivariable logistic regression model, older age, higher heart rate, not undergoing surgery, higher baseline SOFA score, and not escalating antibiotics in face of “PCT alert” were associated with a prolonged ICU stay. The odds ratio of antibiotic escalation for PIS was 0.582 (95% CI: 0.365, 0.926, P=0.022). Conclusions Using PCT to guide antibiotic escalation when pathogen evidence is unavailable could be associated with a shorter length of ICU stay for ICU patients of suspected bacterial infection.

Deescalation Therapy for Severe Nosocomial Pneumonia and Clinical Using of Teicoplanin

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Effect of bronchoalveolar lavage on the use of antibiotics in patients with severe pneumonia

Effect of Piperacillin/tazobactam on Treating Traumatic Brain Injury with Pulmonary Infection: a Clinical Observation

Impact of a Comprehensive Antimicrobial Stewardship Program on Antimicrobial Utilization and Clinical Isolates Distribution in ICUs

Study on the Clinical Pathway of Community Acquired Pneumonia

The application of reduced glutathione in the treaatment of severe pneumonia

Clinical Effect of Antibiotic Therapy in The Treatment of Severe Pneumonia in Elderly Patients

An Evaluation of Clinical Pulmonary Infection Score on the Course of Antimicrobial Therapy in Patients with Clinical Suspected Hospital Acquired Lower Respiratory Tract Infection

Treatment of Teicoplanin for Severe Brain Injury Complicated with Nosocomial Pneumonia.

A Multicenter Clinical Trial on the Efficacy and Safety of Piperacillin/tazobactam for the Treatment of Patients with Hospital Acquired Pneumonia: Treatment of Hospital Acquired Pneumonia Forum in Huadong Area.

Clinical Analysis of Therapeutic Drug Monitoring and Drug Dosage for ICU Patients Treated with Teicoplanin

Efficacy of teicoplanin in treatment of Gram-positive coccal lower respiratory tract infection among elderly patients.

An agent-based model on antimicrobial de-escalation in intensive care units: Implications on clinical trial design

Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit

[Clinical Study of Teicoplanin in the Treatment of Patients with Gram-Positive Cocci: the Chinese Experience].

Epidemiology and Outcomes of Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals

De-escalation Antibiotic Therapy Alleviates Organ Injury Through Modulation of NETs Formation During Sepsis

Antibiotic De-escalation Patterns and Outcomes in Critically Ill Patients with Suspected Pneumonia as Informed by Bronchoalveolar Lavage Results

Pharmacist-Driven Dosing Services and Pharmaceutical Care Increase Probability of Teicoplanin Target Concentration Attainment and Improve Clinical and Economic Outcomes in Non-Critically Ill Patients

Effect of antimicrobial de-escalation strategy on 14-day mortality among intensive care unit patients: a retrospective propensity score-matched cohort study with inverse probability-of-treatment weighting